Patent · US Active

Micromonospora species that produces a bafilomycin-like metabolite

US7803600B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE
Michel Janicot · Brussels, BE
Ursula Maria Mocek · Bellevue, US
Jodi A. Laakso · North Bend, US

Key dates

Filing date	Mar 12, 2007
Grant date	Sep 28, 2010
Priority date	—
Expiry date	Feb 22, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/29
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I) and pharmaceutically acceptable salts thereof. Processes for the isolating of this bafilomycin metabolite from a novel Micromonospora species, pharmaceutical compositions containing this metabolite and methods of treatment using said metabolite are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.